Full Breakdown
Supreme Court Weighs Federal Preemption in Roundup Cancer Lawsuits
4/28/2026, 11:13:47 AM
Core Dispute
The U.S. Supreme Court heard oral arguments on April 27 2026 in *Monsanto v. Durnell*, a case that asks whether the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) preempts state-law “failure-to-warn” claims after the Environmental Protection Agency (EPA) has not required a cancer warning on Roundup, the glyphosate-based herbicide owned by Bayer AG.
Background & Context
Glyphosate was classified as “probably carcinogenic to humans” by the World Health Organization’s International Agency for Research on Cancer in 2015, while the EPA has repeatedly concluded the chemical is “unlikely to be a human carcinogen.” Since Bayer’s 2018 $63 billion acquisition of Monsanto, more than 100,000 plaintiffs have sued alleging Roundup caused non-Hodgkin lymphoma and other cancers. Bayer has set aside $16 billion for settlements and proposed a $7.25 billion class-action deal that does not cover pending appeals.
Key Figures & Groups
- John Durnell – St. Louis “spray guy” who won a $1.25 million jury verdict in 2023.
- Bayer AG / Monsanto – Defendants arguing federal preemption.
- EPA – Federal regulator that approved Roundup’s label without a cancer warning.
- President Donald Trump – Backed Bayer, filing briefs and issuing an executive order invoking the Defense Production Act to protect glyphosate production.
- Health Secretary Robert F. Kennedy Jr. – Leader of the Make America Healthy Again (MAHA) movement opposing the administration’s stance.
- Modern Ag Alliance – Bayer-affiliated farm group supporting the liability shield.
Timeline
- 2015: IARC labels glyphosate “probably carcinogenic.”
- 2018: Bayer acquires Monsanto.
- 2019: Durnell files suit in Missouri state court.
- 2023: Missouri jury awards Durnell $1.25 million.
- 2025: State appeals court upholds verdict.
- April 27 2026: Supreme Court oral arguments.
- June–July 2026: Court expected to issue decision.
Data & Statistics
- > 100,000 Roundup claims filed nationwide.
- $16 billion earmarked by Bayer for settlements.
- $7.25 billion proposed class-action settlement covering most current claims.
- $1.25 million awarded to Durnell; over $10 billion already spent on settlements.
Why It Matters
A ruling in Bayer’s favor could bar thousands of state-law suits, limiting plaintiffs’ ability to seek redress and potentially allowing Bayer to continue selling glyphosate to U.S. farmers. Opponents warn that eliminating lawsuits would reduce incentives for safer formulations and could force Bayer to withdraw glyphosate from the agricultural market, threatening food-supply stability.
Official Statements & Responses
Bayer argues that FIFRA’s preemption clause mandates uniform national labeling and that allowing divergent state warnings would “undermine uniformity” and expose farmers to crippling liability. The EPA maintains its scientific assessment finds no cancer risk when Roundup is used as directed. Durnell’s counsel contends that state law can require additional warnings and that “things slip through the cracks” with the agency’s review process.
Criticism & Opposition
MAHA activists, environmental groups, and consumer-rights lawyers assert that federal preemption would shield corporations from accountability and that state courts provide a necessary safety net when scientific evidence evolves. Agricultural groups such as the American Farm Bureau Federation warn that a loss of glyphosate could create a “devastating risk to America’s food supply.”
Conflicting Reports & Gaps
The WHO’s IARC classification and the EPA’s determination diverge on glyphosate’s carcinogenicity. Estimates of total claims range from 100,000 to 200,000, reflecting incomplete reporting across state and federal courts.
Verbatim Quotes
- “EPA registers pesticides only if EPA approves their labels as adequate to protect health,” — Sarah Harris, Principal Deputy Solicitor General
- “The states cannot do anything?” — Chief Justice John Roberts
- “You think it’s uniformity when each state can require different things?” — Justice Brett Kavanaugh
- “I think there are a lot of conscientious people working at that agency,” — Ashley Keller, attorney for Durnell
- “This case will determine whether people who are harmed by pesticides can have access to courts to seek redress,” — Patti Goldman, Earthjustice
- “It really puts a risk on the availability of not just glyphosate moving forward, but really all products,” — Elizabeth Burns-Thompson, Modern Ag Alliance
What’s Next
The Court is slated to rule by late June or early July 2026. The decision will shape the viability of the $7.25 billion settlement, influence pending state legislation on pesticide liability, and affect Bayer’s strategy for glyphosate’s future in U.S. agriculture.
